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PREFORMED antibodies (Abs) in the blood circulation 
of recipients before transplantation have been identi-
fied as the cause of hyperacute rejection (HAR) of the 
grafts. 1.2 However, liver allografts are relatively resistant 
to preformed Abs, and because of conflicting results in 
clinical practice with sensitized recipients, 3 the practical 
significance of lymphocytotoxic antibodies (LAbs) in an 
individual patient is difficult to judge. In this study, we 
sensitized rats with skin or whole blood and examined in 
vivo and in vitro characterization of the preformed Abs by 
actual transplants. LAb assay, flow cytometry, and indi-
rect immunofluorescence (IF) study. 
MATERIALS AND METHODS 
Animals 
Inbred male Lewis (RTlI. LEW) and ACI (RTl a ) rats (Harlan 
Sprague-Dawley. Indianapolis. IN) were used as recipients and 
donors. respectively. 
Sensitization Protocols 
LEW recipients were sensitized with either four successive full-
thickness ACI tail skin grafts (2 cm diameter) at 14-day intervals 
or I mL heparinized ACI whole blood on two different occasions 
at a 7-day interval. 
Experimental DeSign 
Two to 4 weeks or 12 to 15 weeks after completion of the skin 
sensitization. or 1 week after the second blood transfusion. the 
sensitized LEW recipient underwent actual transplantation of 
ACI heart or liver graft. Hearts were placed in the neck by the 
method of Heron.4 Orthotopic liver transplantation was per-
formed according to the method of Kamada.5 Arterial reconstruc-
tion was omitted. Graft rejection was defined by the cessation of 
the graft heart beat or the death of the animal (liver graft). 
followed by histological confirmation. Immediately before test 
transplantation. serum samples were obtained and preformed Abs 
were characterized by in vitro assays. A complement-dependent 
LAb assay was performed using unfractionated donor ACI lym-
phocytes according to the method of Terasaki et al. 6 Titer was 
defined as the most diluted serum samples with more than SO% 
cell lysis. For flowcytometry. ACIlymph node cells were incu-
bated with immune LEW serum samples (1:10.1:100. I:S00. and 
I: 1000 dilution) followed by fluorescein isothiocyanate-conjugated 
goat antirat immunoglobulin (lg)G or IgM Ab (Ins dilution). For 
indirect IF study, immune LEW serum was applied to frozen 
normal ACIliver sections. followed by goat antirat IgM or IgO to 
detect the target antigen specificity. class, and intensity of binding 
in the liver. 
Statistical Analysis 
Results were analyzed by the Mann-Whitney U test. The differ-
ences were considered statistically significant if P < .0 I. 
RESULTS 
Animal Survival 
The heart grafts always were hyperacutely rejected in 9 
hours when transplanted 2 to 4 weeks after skin sensitiza-
tion (Table I). Microscopic examination revealed classic 
HAR with vascular deposition of IgG. Liver allografts 
survived longer than heart grafts and were rejected within 
3 days (Table I). Pathologically, marked platelet plugging 
of the vasculature, congestion, map-like areas of coagUla-
tive necrosis, and diffuse vascular deposition of IgG were 
characteristic findings. Both heart and liver grafts survived 
significantly longer when transplantation was delayed to 12 
to 15 weeks after skin sensitization (Table I). Pathologi-
cally, an accelerated mixed humoral and cellular rejection 
was nearly as common as pure humoral rejection in failed 
heart grafts: on the other hand, most of the failed liver 
grafts showed a mixed humoral and cellular rejection with 
cellular portal infiltration, platelet plugs, infarcts. and focal 
sinusoidal IgG deposits. After prior blood transfusions. a 
slight (statistically insignificant) prolongation of heart al-
lograft and significantly enhanced liver graft survival was 
seen (Table I). All heart grafts showed cellular rejection. 
whereas only one of the failed liver grafts showed classic 
cellular rejection and the others showed marked sinusoidal 
Kupffer's cell hypertrophy and sinusoidallymphohistiocy-
tosis with a modest portal infiltrate. 
In Vitro Analysis of the Preformed Antibodies 
The highest LAb titer was observed 2 to 4 weeks after the 
last skin sensitization. Flow cytometry revealed that mix-
ture of strong IgG and relatively weak IgM LAbs were 
produced. Indirect IF studies revealed intense linear IgG 
~ IgM reactivity with all vascular endothelial cells, bile 
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Table 1. In Vivo and In Vitro Analysis of Preformed Antibodies In Sensitized LEW Recipients 
In Vivo Study 
In Vi1ro Study 
Heart Graft Uver Graft Sensiti· Time Histology 'LAb Titer FACS Indirect IF 
zation (weeks) n Survival (days) MST n Survival (days) MST (rejection type) (Log2) (lgG/IgM) (lgG/IgM) 
None 7 6,6,6,6,6,7, 6 10 9,9,9,9, 10, 10 Cellular 
7 10,10,11, 
12, 13 
Skin O~ 15 .003, .004, .004, 0.07 11 .13, .14, .17, 1.0 Humoral 11.5:!: 1.1 +++1+ +++1 
.01, .03, .04, .33, .8, 1.0, ++ 
.06, .07, .08, 
•. 10,.13,.17, 
.17, .23,.35 
12-15 13 .05, .13, .45, 
.46, .7, .7, .8, 
1.0,3,3,4,4, 
5 
Blood 6 6,6,7,7,8,9 
MST, median survivaltirne (days). 
'Mean ± SD (n = 6-23). 
1.0, 1.4, 
1.4,1.7,3 
0.8 12 .9, 3, 3, 4, 6, 
8,8,9,9, 
9,9,11 
7 6 18,19,21, 
22, 78, 79 
duct epithelial cells, and weaker hepatocyte staining (Ta· 
ble I). LAb titer was significantly decreased after 12 to 15 
weeks from skin sensitization. With flow cytometry, the 
decrease in titer was noted by a shift to a lower channel 
intensity for both IgO and IgM. Indirect IF of the sera 
showed a decreased binding, greater for IgM than IgO 
compared to the 2- to 4-week sera (Table O. After blood 
sensitization, LAb titer was as high as that of 12 to 15 
weeks after skin sensitization. Stronger IgM and weaker 
IgO Ab response compared to those of 2 to 4 weeks after 
skin sensitization was detected by flowcytometry. By 
indirect IF, sera after blood sensitization reacted only 
weakly with hematolymphoid cells (IgM > IgO) amidst the 
portal connective tissue. The larger vessel endothelium 
was only weakly or equivocally positive (Table I). 
DISCUSSION 
At least three factors-type of organ allograft, time 
elapsed after priming, and organ used for sensitization-
influence allograft outcomes. The liver graft is not only 
resistant to Ab-mediated rejection7 but more easily en-
hanced. And, as others have claimed for cardiac grafts,8 
the time elapsed after priming prolongs the allograft sur-
vival with the decrease of LAb titer. This result suggests 
that determination of Ab titer may increase the predictive 
value of the cross-match test. However, it is clear that the 
LAb titer alone does not sufficiently explain the results 
obtained with different methods of sensitization. Similar 
high LAb titers were observed in animals that hyper-
acutely rejected the grafts and experienced enhancement. 
The better clue to explain such disparate results has come 
8 Humoral or mixed 9.3:!: 1.2 + + I:!: ++1-
(humoral and 
cellular) 
21.5 Cellular or no 10.1 :!: 1.0 +1++ :!:/+ 
from indirect IF analysis, which showed differences in 
target antigen specificity in the liver depending upon the 
method of sensitization. Such an observation is in accord 
with most clinical studies in which IgO Abs, in contrast to 
IgM, with endothelial cell specificity have seemed the most 
dangerous.9 •lo The titer, class, and specificity of Abs 
varied with the length of time after sensitization or sensi-
tization method. A more precise characterization of pre-
formed Abs may increase the ability to predict outcome of 
liver transplantation in sensitized recipients or guide pre-
transplant strategies to foster enhancing Abs. 
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